Monday, May 18, 2015

Gulf War Illness CDMRP Funding Announcement for Researchers

The treatment-focused Gulf War Illness Research Program (GWIRP), part of the Congressionally Directed Medical Research Program (CDMRP) within the Department of Defense, has released its annual research funding announcement for Fiscal Year 2015 (FY15).

The text of the funding announcement is below, and is available online, where researchers can submit their research funding pre-application online at the link below.

*****
SOURCE:  GWIRP CDMRP, http://cdmrp.army.mil/funding/gwirp.shtml

ARCHIVED TEXT:

FY15 Gulf War Illness Research Program (GWIRP)

Synopsis of FY15 GWIRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.
MechanismRelease DateProgram Announcement/InstructionsSubmission Deadline 
NEW! Gulf War Illness Epidemiology Research AwardMay 14, 2015Program Announcement
Application Instructions (external link)
Pre-Application: July 9, 2015
Invitation to Submit an Application: August 2015
Invited Application: October 29, 2015
Submit Pre-Application
New Investigator AwardMay 14, 2015Program Announcement
Application Instructions (external link)
Pre-Application (Letter of Intent): October 15, 2015
Application: October 29, 2015
Submit Pre-Application
Investigator-Initiated Research AwardMay 14, 2015Program Announcement
Application Instructions (external link)
Pre-Application: July 9, 2015
Invitation to Submit an Application: August 2015
Invited Application: October 29, 2015
Submit Pre-Application
Innovative Treatment Evaluation AwardMay 14, 2015Program Announcement
Application Instructions (external link)
Pre-Application: July 9, 2015
Invitation to Submit an Application: August 2015
Invited Application: October 29, 2015
Submit Pre-Application
Clinical Trial Award May 14, 2015Program Announcement
Application Instructions (external link)
Pre-Application: July 9, 2015
Invitation to Submit an Application: August 2015
Invited Application: October 29, 2015
Submit Pre-Application

Quick Links:

For further information, please send e-mail to:

No comments: